Cagrilintide
Clinical TrialsCagrilintide
- Category
- Weight Loss & Metabolism
- Aliases
- CagriSema (combo with semaglutide)
- Administration
- Subcutaneous injection (once weekly)
Documented benefits
Tier 1 · Peer-reviewed / regulatoryBenefit categories
Weight Loss & Metabolism
Cagrilintide's defining research application — the only amylin-mimicking peptide in this database, distinct from GLP-1 drugs.
Appetite suppression
Adds a second, independent layer of appetite suppression by mimicking amylin rather than GLP-1.
Weight loss
Produces additive weight loss when combined with a GLP-1 drug, via a completely separate hormone pathway.
Blood sugar regulation
Amylin's natural role in slowing gastric emptying contributes to steadier post-meal blood sugar.